Immune booster reduces secondary infections in COVID-19 patients

Immune booster reduces secondary infections in COVID-19 patients

A clinical trial led by Richard S. Hotchkiss, MD, a professor of anesthesiology at WashU Medicine, has found that treating critically ill COVID-19 patients with an immune-boosting protein reduces life-threatening secondary infections, a major cause of death in such patients.
WashU named a Voter Friendly Campus

WashU named a Voter Friendly Campus

WashU has once again been named a Voter Friendly Campus, one of 272 campuses nationwide that have successfully implemented practices that encourage students to register and vote.
Chacko selected for Difficult Dialogues center board

Chacko selected for Difficult Dialogues center board

Jacob Chacko, inaugural executive director of WashU’s Center for Diversity & Inclusion and interim director of the Spectrum office in the Division of Student Affairs, has been chosen to serve on the Difficult Dialogues National Resource Center’s board of directors.
View More Stories